192 related articles for article (PubMed ID: 22346351)
1. The comparison of different daidzein-PLGA nanoparticles in increasing its oral bioavailability.
Ma Y; Zhao X; Li J; Shen Q
Int J Nanomedicine; 2012; 7():559-70. PubMed ID: 22346351
[TBL] [Abstract][Full Text] [Related]
2. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery.
Song J; Fan X; Shen Q
Int J Pharm; 2016 Mar; 501(1-2):245-52. PubMed ID: 26851353
[TBL] [Abstract][Full Text] [Related]
3. An HPLC method for the pharmacokinetic study of daidzein-loaded nanoparticle formulations after injection to rats.
Zhao X; Shen Q; Ma Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):113-6. PubMed ID: 21112820
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of the hydrophobic chemopreventive agent (SR13668) in beagle dogs.
Banerjee AA; Shen H; Hautman M; Anwer J; Hong S; Kapetanovic IM; Liu Y; Lyubimov AV
Curr Pharm Biotechnol; 2013; 14(4):464-9. PubMed ID: 23590143
[TBL] [Abstract][Full Text] [Related]
6. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of insulin-loaded bioadhesive PLGA nanoparticles for oral administration.
Zhang X; Sun M; Zheng A; Cao D; Bi Y; Sun J
Eur J Pharm Sci; 2012 Apr; 45(5):632-8. PubMed ID: 22248882
[TBL] [Abstract][Full Text] [Related]
8. Development and optimisation of 3-Acetyl-11-keto-β-boswellic acid loaded poly-lactic-co-glycolic acid-nanoparticles with enhanced oral bioavailability and in-vivo anti-inflammatory activity in rats.
Bairwa K; Jachak SM
J Pharm Pharmacol; 2015 Sep; 67(9):1188-97. PubMed ID: 25851251
[TBL] [Abstract][Full Text] [Related]
9. Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo.
Mittal G; Sahana DK; Bhardwaj V; Ravi Kumar MN
J Control Release; 2007 May; 119(1):77-85. PubMed ID: 17349712
[TBL] [Abstract][Full Text] [Related]
10. Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.
Saez A; Guzmán M; Molpeceres J; Aberturas MR
Eur J Pharm Biopharm; 2000 Nov; 50(3):379-87. PubMed ID: 11072195
[TBL] [Abstract][Full Text] [Related]
11. PLGA nanoparticles for the oral delivery of 5-Fluorouracil using high pressure homogenization-emulsification as the preparation method and in vitro/in vivo studies.
Li X; Xu Y; Chen G; Wei P; Ping Q
Drug Dev Ind Pharm; 2008 Jan; 34(1):107-15. PubMed ID: 18214762
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum.
Surolia R; Pachauri M; Ghosh PC
J Biomed Nanotechnol; 2012 Feb; 8(1):172-81. PubMed ID: 22515105
[TBL] [Abstract][Full Text] [Related]
13. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Siu FY; Ye S; Lin H; Li S
Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of 5-aminolevulinic acid (ALA) loaded PLGA nanoparticles.
Shi L; Wang X; Zhao F; Luan H; Tu Q; Huang Z; Wang H; Wang H
Int J Nanomedicine; 2013; 8():2669-76. PubMed ID: 23926429
[TBL] [Abstract][Full Text] [Related]
15. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies.
Liu Y; Wu X; Mi Y; Zhang B; Gu S; Liu G; Li X
Drug Deliv; 2017 Nov; 24(1):443-451. PubMed ID: 28165858
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bioavailability and intestinal uptake of Gemcitabine HCl loaded PLGA nanoparticles after oral delivery.
Joshi G; Kumar A; Sawant K
Eur J Pharm Sci; 2014 Aug; 60():80-9. PubMed ID: 24810394
[TBL] [Abstract][Full Text] [Related]
17. In vitro schistosomicidal activity of the lignan (-)-6,6'-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni.
Lima TC; Lucarini R; Luz PP; de Faria EH; Marçal L; Magalhães LG; Badoco FR; Esperandim VR; Molina EF; Laurentz RS; Lima RG; Cunha WR; Bastos JK; Silva MLA
Pharm Biol; 2017 Dec; 55(1):2270-2276. PubMed ID: 29172838
[TBL] [Abstract][Full Text] [Related]
18. Optimization of Lurasidone HCl-Loaded PLGA Nanoparticles for Intramuscular Delivery: Enhanced Bioavailability, Reduced Dosing Frequency, Pharmacokinetics, and Therapeutic Outcomes.
Macwan N; Patel HS; Sharma RK; Jain N; Tandel H
Assay Drug Dev Technol; 2024; 22(2):53-62. PubMed ID: 38150562
[No Abstract] [Full Text] [Related]
19. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
[TBL] [Abstract][Full Text] [Related]
20. Encapsulation of low lipophilic and slightly water-soluble dihydroartemisinin in PLGA nanoparticles with phospholipid to enhance encapsulation efficiency and in vitro bioactivity.
Wang L; Wang Y; Wang X; Sun L; Zhou Z; Lu J; Zheng Y
J Microencapsul; 2016 Feb; 33(1):43-52. PubMed ID: 26626402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
